Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 12:46 PM
Ignite Modification Date:
2025-12-25 @ 12:14 PM
NCT ID:
NCT02614261
Group ID:
EG003
Title:
Placebo/Galcanezumab - Open-Label Extension Phase
Description:
After completion of Placebo double-blind phase, participants had an option to enter open-label extension phase where they received 240 mg galcanezumab SC at first month, 120mg at second month followed by 120mg or 240mg once a month (at the discretion of the investigator) for the remaining 7 months.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
16
Serious Number At Risk:
501
Other Number Affected:
223
Other Number At Risk:
501
Study:
NCT02614261
Results Section:
NCT02614261
Adverse Events Module:
NCT02614261